Helps a clinical trial team  discuss
the clinical goals  of a well-defined biomarker with a diagnostic,
staging, prognostic, or predictive purpose.  From this discussion will
come a statistical plan for a (non-randomized) validation trial.
Both prospective and retrospective trials are supported. In a specific
focused discussion, investigators should determine the range of
"discomfort" for the NNT, number needed to treat.  The meaning of
the discomfort range, [NNTlower, NNTupper], is that within this range
most physicians would feel discomfort either in treating or withholding
treatment. A pair of NNT values bracketing that range, NNTpos and NNTneg,
become the targets of the study's design.  If the trial can demonstrate
that a positive biomarker test yields an NNT less than NNTlower,
and that a negative biomarker test yields an NNT less than NNTlower,
then the biomarker may be useful for patients. A highlight of the package
is visualization of a "contra-Bayes" theorem, which produces criteria for
retrospective case-controls studies.

Calculate Design Parameters for Biomarker Validation Studies

package-ubuntu-20.04-r-4.0.5#cran#NNTbiomarker-0.29.11

Compute NNT values from sensitivity aand specificity.

<table summary="R argblock">
<tr valign="top">
<td><code>se</code></td>
<td>
Positive predictive value
</td>
</tr>
<tr valign="top">
<td><code>sp</code></td>
<td>
Negative predictive value
</td>
</tr>
<tr valign="top">
<td><code>sesp</code></td>
<td>
Alternative input for se and sp, as matrix or named vector.
</td>
</tr>
<tr valign="top">
<td><code>prev</code></td>
<td>
Prevalence (prior probability)
</td>
</tr>
</table>

package-ubuntu-20.04-r-4.0.5#cran#NNTbiomarker-0.29.11#docs#NNT.from.sesp

NNT.from.sesp

Description

Usage

Arguments

Value

NNTbiomarker

We don't support your browser anymore

`se`	Positive predictive value
`sp`	Negative predictive value
`sesp`	Alternative input for se and sp, as matrix or named vector.
`prev`	Prevalence (prior probability)